Abstract
The syndrome that is characterized by obesity, insulin resistance, and hyperlipidemia is increasingly prevalent in all prosperous societies. It is now recognized as a major contributor to cardiovascular disease. Vascular dysfunction in the form of hypercontractility and impaired nitric oxide-mediated relaxation is a significant component of cardiovascular disease, predisposing to ischemic events. The JCR:LA-cp strain of rats exhibits all major aspects of the obesity/insulin resistance syndrome, including vascular dysfunction and ischemic lesions of the heart. Dietary lipid intake may have a marked effect on plasma lipid levels and, potentially, on vascular disease. We have investigated the effects of a novel preparation, ONC101 (a phytosterol esterified with fish oil), on plasma lipids and vascular function in the insulin-resistant JCR:LA-cp rat. Treatment of obese male rats with ONC101 from 8 to 12 wk of age resulted in no change in plasma lipid concentrations at 0.5 g/kg body weight. At the higher dose of 2.6 g/kg, plasma TG fell 50% (1.26 vs. 2.59 mmol/L, P<0.002) and cholesterol esters were significantly reduced (1.34 vs. 1.61 mmol/l, P<0.002). Food intake and body weights were unaffected by ONC101 treatment. At the low dose of 86 mg/kg, the hypercontractility of aortic rings in response to phenylephrine was normalized and the relaxant response to acetylcholine was significantly improved. The results indicate that ONC101 at high doses has significant hypolipidemic effects and, at very low doses, has beneficial effects on endothelial and vascular smooth muscle cell function.
Similar content being viewed by others
Abbreviations
- ACh:
-
acetylcholine
- l NAME:
-
N G-nitro-l-arginine methyl ester
- NO:
-
nitric oxide
- PE:
-
phenylephrine
- VLDL:
-
very low density lipoprotein
References
Eisenberg, D. (1998) The Importance of Lowering Cholesterol in Patients with Coronary Heart Disease, Clin. Cardiol. 21, 81–84.
Hulthe, J., Bokemark, L., Wikstrand, J., and Fagerberg, B. (2000) The Metabolic Syndrome, LDL Particle Size, and Atherosclerosis: The Atherosclerosis and Insulin Resistance (AIR) Study, Atheroscler. Thromb. Vasc. Biol. 20, 2140–2147.
Grundy, S.M. (1998) Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic Syndrome (review), Am. J. Cardiol. 81, 18B-25B.
Gotto, A.M., Jr. (1998) Triglyceride: The Forgotten Risk Factor, Circulation 97, 1027–1028.
Jeppeson, J., Hein, O.H., Suadicani, P., and Gyntelberg, F. (1998) Triglyceride Concentration and Ischemic Heart Disease: An Eight-Year Follow-Up in the Copenhagen Male Study, Circulation 97, 1029–1036.
Després, J.P. (1998) The Insulin Resistance-Dyslipidemic Syndrome of Visceral Obesity: Effect on Patients’ Risk, Obesity Res. 6 (Suppl. 1), 8S-17S.
Després, J.-P., Lamarche, B., Mauriège, P., Cantin, B., Dagenais, G.R., Moorjani, S., and Lupien, P.J. (1996) Hyperinsulinemia as an Independent Risk Factor for Ischemic Heart Disease, N. Engl. J. Med. 334, 952–957.
Russell, J.C., Bar-Tana, J., Shillabeer, G., Lau, D.C.W., Richardson, M., Wenzel, L.M., Graham, S.E., and Dolphin, P.J. (1998) Development of Insulin Resistance in the JCR:LA-cp Rat: Role of Triacylglycerols and Effects of MEDICA 16, Diabetes 47, 770–778.
GISSI-Prevenzione Investigators. (1999) Dietary Supplementation with n−3 Polyunsaturated Fatty Acids and Vitamin E After Myocardial Infarction: Results of the GISSI-Prevenzione Trial, Lancet 354, 447–455.
Burr, M.L., Fehily, A.M., Gilbert, J.F., Rogers, S., Holliday, R.M., Sweetman, P.M., Elwood, P.C., and Deadman, N.M. (1989) Effects of Changes in Fat, Fish, and Fibre Intakes on Death and Myocardial Reinfarction: Diet and Reinfarction Trial (DART), Lancet 30, 757–761.
Singh, R.B., Sharma, J.P., Kumar, R., Rastogi, V., and Moshiri, M. (1997) Randomized, Double-Blind, Placebo-Controlled Trial of Fish Oil and Mustard Oil in Patients with Suspected Acute Myocardial Infarction: The Indian Experiment of Infarct Survival, Cardiovasc. Drugs Ther. 11, 485–491.
Leaf, A., Kang, J.X., Xiao, Y.-F., and Billman, G.E. (1999) n−3 Fatty Acids in the Prevention of Cardiac Arrhythmias, Lipids 34 (Suppl.), S187-S189.
Murphy, M.G., Wright, V., Scott, J., Timmins, A., and Ackman, R.G. (1999) Dietary Menhaden, Seal, and Corn Oils Differentially Affect Lipid and ex vivo Eicosanoid and Thiobarbituric Acid-Reactive Substances Generation in the Guinea Pig, Lipids 34, 115–124.
Harris, W.S. (1989) Fish Oils and Plasma Lipid and Lipoprotein Metabolism in Humans: A Critical Review, J. Lipid Res. 30, 785–807.
Jones, P.J.H., MacDougall, D.E., Ntanios, F., and Vanstone, C.A. (1997) Dietary Phytosterols as Cholesterol-Lowering Agents in Humans, Can. J. Physiol. Pharmacol. 75, 217–227.
Ling, W.H., and Jones, P.J.H. (1995) Dietary Phytosterols: A Review of Metabolism, Benefits and Side Effects, Life Sci. 57, 195–206.
Heinemann, T., Kullak-Ublick, G.A., Pietruck, B., and von Bergmann, K. (1991) Mechanisms of Action of Plant Sterols on Inhibition of Cholesterol Absorption: Comparison of Sitosterol and Sitostanol, Eur. J. Clin. Pharmacol. 40 (Suppl. 1), S59-S63.
Miettinen, T.A., Puska, P., Gylling, H., Vanhanen, H., and Vartiainen, E. (1995) Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population, N. Engl. J. Med. 333, 1308–1312.
Richardson, M., Schmidt, A.M., Graham, S.E., Achen, B., DeReske, M., and Russell, J.C. (1998) Vasculopathy and Insulin Resistance in the JCR:LA-cp Rat, Atherosclerosis 138, 135–146.
Russell, J.C., Koeslag, D.G., Amy, R.M., and Dolphin, P.J. (1989) Plasma Lipid Secretion and Clearance in the Hyperlipidemic JCR:LA-Corpulent Rat, Arteriosclerosis 9, 869–876.
Vance, J.E., and Russell, J.C. (1990) Hypersecretion of VLDL, but Not HDL, by Hepatocytes from the JCR:LA-Corpulent Rat, J. Lipid Res. 31, 1491–1501.
Russell, J.C., Ravel, D., Pégorier, J.-P., Delrat, P., Jochemsen, R., O’Brien, S.F., Kelly, S.E., Davidge, S.T., and Brindley, D.N. (2000) Beneficial Insulin-Sensitizing and Vascular Effects of S15261 in the Insulin-Resistant JCR:LA-cp Rat, J. Pharmacol. Exp. Ther. 295, 753–760.
Russell, J.C., McKendrick, J.D., Dubé, G.P., Dolphin, P.J., and Radomski, M.W. (2001) Effects of LY117018 and the Estrogen Analogue, 17-Ethinylestradiol, on Vascular Reactivity, Platelet Aggregation, and Lipid Metabolism in the Insulin-Resistant JCR:LA-cp Male Rat: Role of Nitric Oxide, J. Cardiovasc. Pharmacol. 37, 119–128.
Dolphin, P.J., Amy, R.M., Koeslag, D.G., Limoges, B.F., and Russell, J.C. (1988) Reduction of Hyperlipidemia in the LA/N-Corpulent Rat by Dietary Fish Oil Containing n−3 Fatty Acids, Biochim. Biophys. Acta 962, 317–329.
Russell, J.C., Amy, R.M., and Dolphin, P.J. (1991) Effect of n−3 Fatty Acids on Atherosclerosis Prone JCR:LA-Corpulent Rats, Exp. Mol. Pathol. 55, 285–293.
Ratnayake, W.M.N., Plouffe, L., Hollywood, R., L’Abbé, M.R., Nidiroglou, N., Sarwar, G., and Mueller, R. (2000) Influence of Sources of Dietary Oils on the Life Span of Stroke-Prone Spontaneously Hypertensive Rats, Lipids 35, 409–419.
Russell, J.C., Amy, R.M., Graham, S.E., Dolphin, P.J., Wood, G.O., and Bar-Tana, J. (1995) Inhibition of Atherosclerosis and Myocardial Lesions in the JCR:LA-cp Rat by β,β′-Tetramethylhexadecanedioic Acid (MEDICA 16), Arterioscler. Thromb. Vasc. Biol. 15, 918–923.
Russell, J.C., Graham, S.E., and Dolphin, P.J. (1999) Glucose Tolerance and Insulin Resistance in the JCR:LA-cp Rat: Effect of Miglitol (Bay m1099), Metabolism 48, 701–706.
O’Brien, S.F., McKendrick, J.D., Radomski, M.W., Davidge, S.T., and Russell, J.C. (1998) Vascular Wall Reactivity in Conductance and Resistance Arteries: Differential Effects of Insulin Resistance, Can. J. Physiol. Pharmacol. 76, 72–76.
Kuksis, A., Myher, J.J., Geher, K., Hoffman, A.G., Breckenridge, W.C., Jones, G.J., and Little, J.A. (1978) Comparative Determination of Plasma Cholesterol and Triacylglycerol Levels by Automated Gas-Liquid Chromatographic and Autoanalyzer Techniques, J. Chromatogr. 146, 393–412.
De Lean, A., Munson, P.J., Guardabaso, V., and Rodbard, D. (1992) A Users’ Guide to ALLFIT, National Institutes of Health, Bethesda.
Absher, P.M., Schneider, D.J., Russell, J.C., and Sobel, B.E. (1997) Increased Proliferation of Explanted Vascular Smooth Muscle Cells: A Marker Presaging Atherogenesis, Atherosclerosis 131, 187–194.
Absher, P.M., Schneider, D.J., Baldor, L.C., Russell, J.C., and Sobel, B.E. (1999) The Retardation of Vasculopathy Induced by Attenuation of Insulin Resistance in the Corpulent JCR:LA-cp Rat Is Reflected by Decreased Vascular Smooth Muscle Cell Proliferation in vivo, Atherosclerosis 143, 245–251.
Tagawa, H., Shimokawa, H., Tagawa, T., Kuroiwa-Matsumoto, M., Hirooka, Y., and Takeshita, A. (1999) Long-Term Treatment with Eicosapentaenoic Acid Augments Both Nitric Oxide-Mediated and Non-Nitric Oxide Mediated Endothelium-Dependent Forearm Vasodilation in Patients with Coronary Artery Disease, J. Cardiovasc. Pharmacol. 33, 633–640.
Goodfellow, J., Bellamy, M.F., Ramsey, M.W., Jones, C.J.H., and Lewis, M.J. (2000) Dietary Supplementation with Marine Omega-3 Fatty Acids Improve Systemic Large Artery Endothelial Function in Subjects with Hypercholesterolemia, J. Am. Coll. Cardiol. 35, 265–270.
O’Brien, S.F., and Russell, J.C. (1997) Insulin Resistance and Vascular Wall Function: Lessons from Animal Models (review), Endocrinol. Metab. 4, 155–162.
Schneider, D.J., Absher, P.M., Neimane, D., Russell, J.C., and Sobel, B.E. (1998) Fibrinolysis and Atherogenesis in the JCR:LA-cp Rat in Relation to Insulin and Triglyceride Concentrations in Blood, Diabetologia 41, 141–147.
Author information
Authors and Affiliations
Corresponding author
Additional information
Deceased, June 22, 2001.
About this article
Cite this article
Russell, J.C., Ewart, H.S., Kelly, S.E. et al. Improvement of vascular dysfunction and blood lipids of insulin-resistant rats by a marine oil-based phytosterol compound. Lipids 37, 147–152 (2002). https://doi.org/10.1007/s11745-002-0874-6
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11745-002-0874-6